Abstract
Atherosclerosis is a chief cause of heart attack, stroke and death in Western society. It is a disease of the large arteries characterised by the presence of atherosclerotic lesions, often observable as fatty streaks within the first decade of life. A number of factors influence the development and progression of atherosclerosis; however, hemodynamic forces appear to play a critical role in the earliest stages of lesion formation. Significantly, lesions selectively develop in the areas of the vasculature associated with low shear stress, such as at the bends and bifurcations of the arterial tree. In contrast, areas subjected to uniform laminar flow, as found in the straight tubular portions of arteries are considered athero-resistant. Hemodynamic forces influence the transcription of genes within the endothelial cells that line the entire vascular system. Transcriptional changes include the modulation of genes encoding cytokines, adhesion molecules, transcription factors and growth factors. Shear stress-responsive gene expression may underpin the role that hemodynamic forces play in vascular homeostasis and pathophysiology; however, it is not clear exactly how hemodynamic forces influence the genesis and progression of atherosclerosis. DNA microarray technology has recently been employed to identify novel hemodynamic flow-responsive genes and gene families. In the current study we compile such gene expression data from large-scale transcriptomic profiling and examine it within the pathological context of atherosclerosis. By understanding the molecular mechanisms underlying the role that hemodynamic forces play in the pathogenesis of vascular disease it may be possible to identify central mediators of the disease and to design new therapeutic strategies.
Keywords: shear stress, laminar flow, disturbed flow, dna microarray
Current Genomics
Title: Profiling the Shear Stress of Atherosclerosis; A Genomic View
Volume: 5 Issue: 4
Author(s): C. Stenson-Cox, V. Barron, B. P. Murphy, P. E. McHugh and T. Smith
Affiliation:
Keywords: shear stress, laminar flow, disturbed flow, dna microarray
Abstract: Atherosclerosis is a chief cause of heart attack, stroke and death in Western society. It is a disease of the large arteries characterised by the presence of atherosclerotic lesions, often observable as fatty streaks within the first decade of life. A number of factors influence the development and progression of atherosclerosis; however, hemodynamic forces appear to play a critical role in the earliest stages of lesion formation. Significantly, lesions selectively develop in the areas of the vasculature associated with low shear stress, such as at the bends and bifurcations of the arterial tree. In contrast, areas subjected to uniform laminar flow, as found in the straight tubular portions of arteries are considered athero-resistant. Hemodynamic forces influence the transcription of genes within the endothelial cells that line the entire vascular system. Transcriptional changes include the modulation of genes encoding cytokines, adhesion molecules, transcription factors and growth factors. Shear stress-responsive gene expression may underpin the role that hemodynamic forces play in vascular homeostasis and pathophysiology; however, it is not clear exactly how hemodynamic forces influence the genesis and progression of atherosclerosis. DNA microarray technology has recently been employed to identify novel hemodynamic flow-responsive genes and gene families. In the current study we compile such gene expression data from large-scale transcriptomic profiling and examine it within the pathological context of atherosclerosis. By understanding the molecular mechanisms underlying the role that hemodynamic forces play in the pathogenesis of vascular disease it may be possible to identify central mediators of the disease and to design new therapeutic strategies.
Export Options
About this article
Cite this article as:
Stenson-Cox C., Barron V., Murphy P. B., McHugh E. P. and Smith T., Profiling the Shear Stress of Atherosclerosis; A Genomic View, Current Genomics 2004; 5 (4) . https://dx.doi.org/10.2174/1389202043349327
DOI https://dx.doi.org/10.2174/1389202043349327 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Targeting Leukostasis for the Treatment of Early Diabetic Retinopathy
Cardiovascular & Hematological Disorders-Drug Targets Recombinant Snake Venom Cystatin Inhibits Tumor Angiogenesis in vitro and in vivo Associated with Downregulation of VEGF-A165, Flt-1 and bFGF
Anti-Cancer Agents in Medicinal Chemistry The Relationship Between HIV Infection and Cardiovascular Disease
Current Cardiology Reviews The Role of Cytochrome P450 in Herb-Drug Interactions
Current Pharmacogenomics Rationale for Development of New Oral Anticoagulants
Cardiovascular & Hematological Disorders-Drug Targets Why Does Obesity Increase the Risk for Cardiovascular Disease?
Current Pharmaceutical Design Evidence of Redox Unbalance in Post-Acute Ischemic Stroke Patients
Current Neurovascular Research Cardiovascular Risk and Endothelial Dysfunction: The Preferential Route for Atherosclerosis
Current Pharmaceutical Biotechnology Dynamics of Telomere Length in Different Age Groups in a Latvian Population
Current Aging Science Ocular Vascular Involvement in the Rheumatic Diseases
Current Rheumatology Reviews Targeting Drugs to APJ Receptor: The Prospect of Treatment of Hypertension and Other Cardiovascular Diseases
Current Drug Targets Diagnostic Tools for Diabetic Sensorimotor Polyneuropathy
Current Diabetes Reviews Managing Cardiovascular Risk Factors without Medications: What is the Evidence?
Cardiovascular & Hematological Agents in Medicinal Chemistry Aporphine Alkaloids and their Antioxidant Medical Application: From Antineoplastic Agents to Motor Dysfunction Diseases
Current Organic Chemistry Agents for the Treatment of Glycosphingolipid Storage Disorders
Current Drug Metabolism Old And New Oral Anticoagulants In Management Of Atrial Fibrillation: A Double-Edged Sword For Women
Current Vascular Pharmacology Cardiovascular Diseases and the Nitric Oxide Pathway
Current Vascular Pharmacology The Role of Physical Exercise and Omega-3 Fatty Acids in Depressive Illness in the Elderly
Current Neuropharmacology Current Options and Perspectives in the Treatment of Diabetic Neuropathy
Current Pharmaceutical Design Role of Focal Adhesion Kinase in Human Cancer: A Potential Target for Drug Discovery
Anti-Cancer Agents in Medicinal Chemistry